Telephone and Data Systems still owns 4,409 towers and 30% of its spectrum assets. The $4.4 billion TMUS deal is set to close ...

Fortified Balance Sheet of $113.0 Million Enables Company to continue R&D activities in AI-Driven Customer Platform in other Corporate ...

Shares of Capricor Therapeutics (CAPR) are trading up by about 13% on Thursday noon after the company announced ...

Inc. were $7.5 billion, down 2 percent compared to the prior year, reflecting product mix shifts, partially offset ...

In September 2024, announced an exclusive worldwide license agreement with BioAtla, Inc. to develop and commercialize CT-202, a Nectin-4 x CD3 T cell engaging bispecific antibody. Context expects to ...

MacroGenics (NASDAQ: MGNX) Q4 2024 Earnings Call Mar 20, 2025, 4:30 p.m. ET ...

Q4 2024 Management View CEO Punit Dhillon highlighted significant progress with the clinical development of nimacimab, including the completion of patient enrollment for the CBeyond Phase IIa trial ...

Remains on Track to Initiate an Expansion Study of NUC-7738 in Combination with Pembrolizumab for Patients with PD-1 Inhibitor-Resistant Melanoma in 2025 ...

Shares of information-technology contractors such as Booz Allen Hamilton Holding (NYSE:BAH), Gartner (NYSE:IT), Accenture ...

Monthly recurring revenue up 24.4% at December 31, 2024; Operating and net profit generated in H2 2024 thanks to operational leverage and cost control; Gross cash and cash equivalents over €11 ...

Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac") shareholder Heng Ren Partners, LLC funds ("Heng Ren") today sent an open letter to Sinovac's shareholders ...

Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its fourth quarter ...